Q2 2017 Holdings
Filed 2017-08-14 | 41 holdings | $57.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axogen Inc(AXGN) | COM | 05463X106 | $33.0M | 1,970,000 | 57.1% |
| Codexis Inc(CDXS) | COM | 192005106 | $8.0M | 1,470,000 | 13.9% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $7.1M | 460,000 | 12.3% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $6.7M | 130,000 | 11.6% |
| Ardelyx(ARDX) | COM | 039697107 | $2.8M | 546,500 | 4.8% |
| Blueprint Medicines(2L9) | COM | 09627Y109 | $44.6K | 880,000 | 0.1% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $11.6K | 360,000 | 0.0% |
| Loxo Oncology | COM | 548862101 | $10.4K | 130,000 | 0.0% |
| Strongbridge Biopharma PLC | COM | G85347105 | $8.4K | 1,180,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $7.9K | 900,000 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $7.6K | 450,000 | 0.0% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $7.2K | 180,000 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $7.0K | 1,280,000 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $6.9K | 750,000 | 0.0% |
| Corium International Inc | COM | 21887L107 | $5.3K | 715,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $5.3K | 1,135,000 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $5.1K | 580,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $5.1K | 290,000 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $4.7K | 60,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $4.6K | 85,000 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $3.6K | 100,000 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $3.6K | 120,300 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $3.0K | 100,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $2.9K | 150,000 | 0.0% |
| Imprimis Pharmaceuticals Inc | COM NEW | 45323A201 | $2.9K | 895,000 | 0.0% |
| Tetraphase Pharmaceuticals I | COM | 88165N105 | $2.4K | 330,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $2.3K | 125,000 | 0.0% |
| Aratana Therapeutics Inc(PETXEUR) | COM | 03874P101 | $2.3K | 350,200 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $2.2K | 317,200 | 0.0% |
| Mirna Therapeutics Inc | COM | 60470J103 | $1.9K | 1,148,100 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $1.8K | 109,500 | 0.0% |
| Zosano Pharma Corp | COM | 98979H103 | $1.7K | 1,225,000 | 0.0% |
| Tonix Pharmaceuticals Holding | COM NEW | 890260201 | $1.6K | 370,000 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365AAB7 | $1.5K | 1,835,000 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $1.3K | 130,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $1.2K | 970,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $1.1K | 40,000 | 0.0% |
| Intra Cellular Therapies Inc | COM | 04611X101 | $1.1K | 85,000 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $1.0K | 380,000 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $365 | 50,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $212 | 250,000 | 0.0% |